NorthRock Partners’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
NorthRock Partners's AZR Position: Q4 2021 in Review
NorthRock Partners sold out of Azora Therapeutics (AZR) in Q4 2021, closing a stake of 16 shares — an estimated $43K sold.
NorthRock Partners first reported a position in AZR in Q3 2021 and held it in 1 quarter. The position peaked at $43K in Q3 2021. 23 funds tracked by Wall St. Rank hold AZR as of Q4 2021.
- NorthRock Partners reported no remaining Azora Therapeutics position as of Q4 2021 after selling out during the quarter.
- NorthRock Partners sold 16 Azora Therapeutics shares in Q4 2021, an estimated $43K.
- NorthRock Partners first reported a position in Azora Therapeutics in Q3 2021 and held it in 1 quarter.
- NorthRock Partners's Azora Therapeutics position peaked at $43K in Q3 2021.
- 23 funds tracked by Wall St. Rank held Azora Therapeutics as of Q4 2021.
Based on NorthRock Partners's 13F filing for Q4 2021, filed 7 Feb 2022.